Impact of Genetic Modification of Vector Populations on the Malaria Eradication Agenda

Genetic Control of Malaria and Dengue

Volumn , Issue , 2016, Pages 423-444

  Macias, Vanessa ^a   James, Anthony A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Genetically engineered mosquitoes; Population modification replacement; Population suppression

Indexed keywords

EID: 85016956219     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-800246-9.00019-3     Document Type: Chapter

References (75)

1. WHO. World malaria report,; 2013 [accessed 02.09.14]. http://www.who.int/malaria/publications/world_malaria_report_2013/report/en/.
2. White N.J., Pukrittayakamee S., Hien T.T., Faiz M.A., Mokuolu O.A., Dondorp A.M. Malaria. Lancet 2014, 383:723-735.
3. Cohen J.M., Smith D.L., Cotter C., et al. Malaria resurgence: a systematic review and assessment of its causes. Malar J 2012, 11:122.
4. Sheffield P.E., Landrigan P.J. Global climate change and children's health: threats and strategies for preventi. Environ Health Perspect 2011, 119:291-298.
5. Antinori S., Galimberti L., Milazzo L., Corbellino M. Plasmodium knowlesi: the emerging zoonotic malaria parasite. Acta Trop 2013, 125:191-201.
6. Calderaro A., Piccolo G., Gorrini C., et al. Accurate identification of the six human Plasmodium spp. causing imported malaria, including Plasmodium ovale wallikeri and Plasmodium knowlesi. Malar J 2013, 12:321.
7. Binka F., Brown A.G., Alonso P.L., et al. A research agenda for malaria eradication: cross-cutting issues for eradication. PLoS Med 2011, 8:e1000404.
8. WHO Procedures for certification of malaria elimination. Wkly Epidemiol Rec 2014, 89:321-325.
9. Alonso P.L., Besansky N.J., Burkot T.R., et al. A research agenda for malaria eradication: vector control. PLoS Med 2011, 8:e1000401.
10. Spielman A., Kitron U., Pollack R.J. Time limitation and the role of research in the worldwide attempt to eradicate malaria. J Med Entomol 1993, 30:6-19.
11. Luckhart S., Lindsay S.W., James A.A., Scott T.W. Reframing critical needs in vector biology and management of vector-borne disease. PLoS Negl Trop Dis 2010, 4:e566.
12. Cotter C., Sturrock H.J.W., Hsiang M.S., et al. The changing epidemiology of malaria elimination: new strategies for new challenges. Lancet 2013, 382:900-911.
13. Kiszewski A., Mellinger A., Spielman A., Malaney P., Sachs S.E., Sachs J. A global index representing the stability of malaria transmission. Am J Trop Med Hyg 2004, 70:486-498.
14. Hay S.I., Sinka M.E., Okara R.M., et al. Developing global maps of the dominant anopheles vectors of human malaria. PLoS Med 2010, 7:e1000209.
15. Elyazar I.R.F., Sinka M.E., Gething P.W., et al. The distribution and bionomics of anopheles malaria vector mosquitoes in Indonesia. Adv Parasitol 2013, 83:173-266.
16. Hardy J.L., Houk E.J., Kramer L.D., Reeves W.C. Intrinsic factors affecting vector competence of mosquitoes for Arboviruses. Annu Rev Entomol 1983, 28:229-262.
17. Smith D.L., Battle K.E., Hay S.I., Barker C.M., Scott T.W., McKenzie F.E. Ross, Macdonald, and a theory for the dynamics and control of mosquito-transmitted pathogens. PLoS Pathog 2012, 8:e1002588.
18. Tatarsky A., Aboobakar S., Cohen J.M., et al. Preventing the reintroduction of malaria in Mauritius: a programmatic and financial assessment. PLoS One 2011, 6:e23832.
19. Sokhna C., Ndiath M.O., Rogier C. The changes in mosquito vector behaviour and the emerging resistance to insecticides will challenge the decline of malaria. Clin Microbiol Infect 2013, 19:902-907.
20. Centers for Disease Control and Prevention Plasmodium vivax malaria - San Diego County, California, 1986. MMWR Morb Mortal Wkly Rep 1986;35:679-81.
21. Klassen W., Curtis C.F. History of the sterile insect technique. The sterile insect technique: principles and practice in area-wide integrated pest management 2005, 3-36. Springer, Dordrecht, The Netherlands. V.A. Dyck (Ed.).
22. Oh, New Delhi, Oh, Geneva [editorial]. Nature 1975;256:355-7.
23. Jayaraman K.S. Consortium aims to revive sterile-mosquito project. Nature 1997, 389:6.
24. Report of the meeting "Prospects for malaria control by genetic manipulation of its vectors", Geneva, Switzerland. WHO TDR/BCV/MAL-ENT/91.3; 1991.
25. Curtis C.F. Possible use of translocations to fix desirable genes in insect pest populations. Nature 1968, 218:368-369.
26. Curtis C.F., Graves P.M. Methods for replacement of malaria vector populations. J Trop Med Hygeine 1988, 91:43-48.
27. Collins F.H., James A.A. Genetic modification of mosquitoes. Sci Med 1996, 3:52-61.
28. Graves P.M., Curtis C.F. A cage replacement experiment involving introduction of genes for refractoriness to Plasmodium yoelii nigeriensis into a population of Anopheles gambiae (Diptera: Culicidae). J Med Entomol 1982, 19:127-133.
29. James A. Control of disease transmission through genetic modification of mosquitoes. Insect transgenesis: methods and applications 2000, 319-332. CRC Press, Boca Raton, FL. A.M. Handler, A.A. James (Eds.).
30. James A.A., Benedict M.Q., Christophides G.K., Jacobs-Lorena M., Olson K.E. Evaluation of drive mechanisms (including transgenes and drivers) in different environmental conditions and genetic backgrounds. Bridging laboratory and field research for genetic control of disease vectors 2006, 149-155. Springer, Dordrecht, The Netherlands. B.G.J. Knols, C. Louis (Eds.).
31. Ito J., Ghosh A., Moreira L.A., Wimmer E.A., Jacobs-Lorena M. Transgenic anopheline mosquitoes impaired in transmission of a malaria parasite. Nature 2002, 417:452-455.
32. Corby-Harris V., Drexler A., Watkins de Jong L., et al. Activation of Akt signaling reduces the prevalence and intensity of malaria parasite infection and lifespan in Anopheles stephensi mosquitoes. PLoS Pathog 2010, 6:e1001003.
33. Isaacs A.T., Jasinskiene N., Tretiakov M., et al. Transgenic Anopheles stephensi coexpressing single-chain antibodies resist Plasmodium falciparum development. Proc Natl Acad Sci USA 2012, 109:E1922-E1930.
34. Marinotti O., Jasinskiene N., Fazekas A., et al. Development of a population suppression strain of the human malaria vector mosquito, Anopheles stephensi. Malar J 2013, 26:142.
35. Galizi R., Doyle L.A., Menichelli M., et al. A synthetic sex ratio distortion system for the control of the human malaria mosquito. Nat Commun 2014, 5:3977.
36. Brown D.M., Alphey L.S., McKemey A., Beech C., James A.A. Criteria for identifying and evaluating candidate sites for open-field trials of genetically engineered mosquitoes. Vector Borne Zoonotic Dis 2014, 14:291-299.
37. Isaacs A.T., Li F., Jasinskiene N., et al. Engineered resistance to Plasmodium falciparum development in transgenic Anopheles stephensi. PLoS Pathog 2011, 7:e1002017.
38. Kitua A.Y. The future of malaria research and control: an African perspective. Afr J Health Sci 1998, 5:58-62.
39. Tusting L.S., Thwing J., Sinclair D., et al. Mosquito larval source management for controlling malaria. Cochrane Database Syst Rev 2013, 8:CD008923.
40. Bian G., Joshi D., Dong Y., et al. Wolbachia invades Anopheles stephensi populations and induces refractoriness to Plasmodium infection. Science 2013, 340:748-751.
41. Alphey N., Alphey L., Bonsall M.B. A model framework to estimate impact and cost of genetics-based sterile insect methods for dengue vector control. PLoS One 2011, 6:e25384.
42. Benedict M., D'Abbs P., Dobson S., et al. Guidance for contained field trials of vector mosquitoes engineered to contain a gene drive system: recommendations of a scientific working group. Vector Borne Zoonotic Dis 2008, 8:127-166.
43. WHO/TDR, FNIH. The Guidance Framework for testing genetically modified mosquitoes,; 2014. http://www.who.int/tdr/publications/year/2014/guide-fmrk-gm-mosquit/en/.
44. Ramsey J.M., Bond J.G., Macotela M.E., et al. A regulatory structure for working with genetically modified mosquitoes: lessons from Mexico. PLoS Negl Trop Dis 2014, 8:e2623.
45. El Sayed B.B., Malcolm C.A., Babiker A., et al. Ethical, legal and social aspects of the approach in Sudan. Malar J 2009, 8(Suppl. 2):S3.
46. Malcolm C.A., El Sayed B., Babiker A., et al. Field site selection: getting it right first time around. Malar J 2009, 8(Suppl. 2):S9.
47. Lavery J.V., Harrington L.C., Scott T.W. Ethical, social, and cultural considerations for site selection for research with genetically modified mosquitoes. Am J Trop Med Hyg 2008, 79:312-318.
48. Hay S.I., Smith D.L., Snow R.W. Measuring malaria endemicity from intense to interrupted transmission. Lancet Infect Dis 2008, 8:369-378.
49. Mnzava A.P., Macdonald M.B., Knox T.B., Temu E.A., Shiff C.J. Malaria vector control at a crossroads: public health entomology and the drive to elimination. Trans R Soc Trop Med Hyg 2014, 108:550-554.
50. Benedict M., D'Abbs P., Dobson S., et al. Arthropod containment guidelines. A project of the American Committee of Medical Entomology and American Society of Tropical Medicine and Hygiene. Vector Borne Zoonotic Dis 2003, 3:61-98.
51. Boëte C., Agusto F.B., Reeves R.G. Impact of mating behaviour on the success of malaria control through a single inundative release of transgenic mosquitoes. J Theor Biol 2014, 347:33-43.
52. Jasinskiene N., Coleman J., Ashikyan A., Salampessy M., Marinotti O., James A.A. Genetic control of malaria parasite transmission: threshold levels for infection in an avian model system. Am J Trop Med Hyg 2007, 76:1072-1078.
53. James A.A. Gene drive systems in mosquitoes: rules of the road. Trends Parasitol 2005, 21:64-67.
54. Catteruccia F., Godfray H.C.J., Crisanti A. Impact of genetic manipulation on the fitness of Anopheles stephensi mosquitoes. Science 2003, 299:1225-1227.
55. Irvin N., Hoddle M.S., O'Brochta D.A., Carey B., Atkinson P.W. Assessing fitness costs for transgenic Aedes aegypti expressing the GFP marker and transposase genes. Proc Natl Acad Sci U S A 2004, 101:891-896.
56. Moreira L.A., Wang J., Collins F.H., Jacobs-Lorena M. Fitness of anopheline mosquitoes expressing transgenes that inhibit Plasmodium development. Genetics 2004, 166:1337-1341.
57. Amenya D.A., Bonizzoni M., Isaacs A.T., et al. Comparative fitness assessment of Anopheles stephensi transgenic lines receptive to site-specific integration. Insect Mol Biol 2010, 19:263-269.
58. Hauck E.S., Antonova-Koch Y., Drexler A., et al. Overexpression of phosphatase and tensin homolog improves fitness and decreases Plasmodium falciparum development in Anopheles stephensi. Microbes Infect 2013, 15:775-787.
59. Carballar-Lejarazú R., Jasinskiene N., James A.A. Exogenous gypsy insulator sequences modulate transgene expression in the malaria vector mosquito, Anopheles stephensi. Proc Natl Acad Sci U S A 2013, 110:7176-7181.
60. Nirmala X., James A.A. Engineering Plasmodium-refractory phenotypes in mosquitoes. Trends Parasitol 2003, 19:384-387.
61. Pike A., Vadlamani A., Sandiford S.L., Gacita A., Dimopoulos G. Characterization of the Rel2-regulated transcriptome and proteome of Anopheles stephensi identifies new anti-Plasmodium factors. Insect Biochem Mol Biol 2014, 52:82-93.
62. Facchinelli L., Valerio L., Ramsey J.M., et al. Field cage studies and progressive evaluation of genetically-engineered mosquitoes. PLoS Negl Trop Dis 2013, 7:e2001.
63. Andreasen M.H., Curtis C.F. Optimal life stage for radiation sterilization of Anopheles males and their fitness for release. Med Vet Entomol 2005, 19:238-244.
64. Dame D.A., Curtis C.F., Benedict M.Q., Robinson A.S., Knols B.G.J. Historical applications of induced sterilisation in field populations of mosquitoes. Malar J 2009, 8(Suppl. 2):S2.
65. Pew Initiative. Bugs in the System: Issues in the Science and Regulation of Genetically Modified Insects. Washington, DC, 2004.
66. Hoffmann A.A., Montgomery B.L., Popovici J., et al. Successful establishment of Wolbachia in Aedes populations to suppress dengue transmission. Nature 2011, 476:454-457.
67. WHO. Progress and prospects for the use of genetically-modified mosquitoes to inhibit disease transmission. In: Report on planning meeting 1: technical consultation on current status and planning for future development of genetically-modified mosquitoes for malaria and dengue control,; 2010. doi:10.2471/TDR.10.978-924-1599238.
68. Peng Z., Simons F.E.R. Advances in mosquito allergy. Curr Opin Allergy Clin Immunol 2007, 7:350-354.
69. Higgs S. Chikungunya virus: a major emerging threat. Vector Borne Zoonotic Dis 2014, 14:535-536.
70. James A.A., Beerntsen B.T., Capurro M., de L., et al. Controlling malaria transmission with genetically-engineered, Plasmodium-resistant mosquitoes: milestones in a model system. Parassitologia 1999, 41:461-471.
71. De Lara Capurro M., Coleman J., Beerntsen B.T., et al. Virus-expressed, recombinant single-chain antibody blocks sporozoite infection of salivary glands in Plasmodium gallinaceum-infected Aedes aegypti. Am J Trop Med Hyg 2000, 62:427-433.
72. Guerra C.A., Reiner R.C., Perkins T.A., et al. A global assembly of adult female mosquito mark-release-recapture data to inform the control of mosquito-borne pathogens. Parasit Vectors 2014, 7:276.
73. James S., Simmons C.P., James A.A. Field trials of modified mosquitoes present complex but manageable challenges. Science 2011, 334:771-772.
74. Christophers S. Aëdes aegypti (L.) the yellow fever mosquito: its life history, bionomics and structure 1960, The Syndics of the Cambridge University Press, London.
75. Rasgon J.L., Scott T.W. Impact of population age structure on Wolbachia transgene driver efficacy: ecologically complex factors and release of genetically modified mosquitoes. Insect Biochem Mol Biol 2004, 34:707-713.